(Q39102186)
Statements
1 reference
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B. (English)
1 reference
S G Lim
1 reference
N Leung
1 reference
H W L Hann
1 reference
G K K Lau
1 reference
C Trepo
1 reference
H Mommeja-Marin
1 reference
C Moxham
1 reference
J Sorbel
1 reference
A Snow
1 reference
M R Blum
1 reference
F Rousseau
1 reference
P Marcellin
1 reference
22 March 2008
1 reference
1 reference
27
1 reference
12
1 reference
1282-1292
1 reference
1 reference
Identifiers
1 reference
1 reference